|
BTF3L4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42360000000708E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.659270E-03 |
| Normal-vs-Stage2 |
1.083000E-01 |
| Normal-vs-Stage3 |
7.65280000036839E-07 |
| Normal-vs-Stage4 |
4.77479999982933E-09 |
| Stage1-vs-Stage2 |
4.446400E-01 |
| Stage1-vs-Stage3 |
5.281600E-03 |
| Stage1-vs-Stage4 |
5.58579999999642E-05 |
| Stage2-vs-Stage3 |
1.619970E-02 |
| Stage2-vs-Stage4 |
2.203500E-03 |
| Stage3-vs-Stage4 |
1.737200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17109999995002E-06 |
| Normal-vs-AfricanAmerican |
6.836400E-02 |
| Normal-vs-Asian |
1.744450E-03 |
| Caucasian-vs-AfricanAmerican |
2.753400E-01 |
| Caucasian-vs-Asian |
6.747200E-01 |
| AfricanAmerican-vs-Asian |
5.085200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85600000002228E-06 |
| Normal-vs-Female |
5.636800E-04 |
| Male-vs-Female |
9.963500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.160400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.630430E-04 |
| Normal-vs-Age(61-80Yrs) |
8.22740000017141E-07 |
| Normal-vs-Age(81-100Yrs) |
2.284600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.896350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.821660E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.612150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.356800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.314010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.704200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.460220E-02 |
| Classical-VS-Follicular |
6.041800E-01 |
| Classical-VS-Other |
9.414800E-01 |
| Classical-VS-Normal |
3.592800E-04 |
| Tall-VS-Follicular |
9.982300E-03 |
| Tall-VS-Other |
2.085400E-01 |
| Tall-VS-Normal |
4.47049999996452E-06 |
| Follicular-VS-Other |
8.305600E-01 |
| Follicular-VS-Normal |
2.411800E-02 |
| Other-VS-Normal |
1.451000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.794800E-04 |
| Normal-vs-N1 |
1.91106999999358E-05 |
| N0-vs-N1 |
1.179630E-01 |
|
|
